Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,594,720
New position
Shares Held
72,000
first reported quarter
Ownership
0.083%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#91
of 302 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026NWI MANAGEMENT LP holds $184,769,247 across 6 Biotechnology names. ABVX ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
1,014,000 | $108,112,680 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
180,000 | $33,710,400 | |
| 3 | NAMS |
NewAmsterdam Pharma Co N.V.
|
702,000 | $23,790,780 | |
| 4 | ABVX |
Abivax S.A.
This page
|
72,000 | $9,594,720 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
241,671 | $9,352,667 | |
| 6 | ALLO |
Allogene Therapeutics, Inc.
|
100,000 | $208,000 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,594,720 | 72,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||